Think Investments’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Think Investments’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-186,373	Closed	-$28.8M	–	12
2015 Q4	$28.8M	Sell	186,373 -32,127	-15%	-$4.69M	8.16%	7
2015 Q3	$31.2M	Buy	218,500 +51,211	+31%	+$7.16M	9.15%	5
2015 Q2	$24M	Hold	167,289	–	–	7.17%	5
2015 Q1	$23.6M	Buy	167,289 +10,489	+7%	+$1.61M	8.72%	7
2014 Q4	$23.2M	Buy	+156,800	New	+$23M	8.27%	6

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Think Investments's TARO Position: Q1 2016 in Review

Think Investments sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2016, closing a stake of 186,373 shares — an estimated $28.8M sold.

Think Investments first reported a position in TARO in Q4 2014 and held it in 5 quarters. The position peaked at $31.2M in Q3 2015. 167 funds tracked by Wall St. Rank hold TARO as of Q1 2016.

Think Investments reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2016 after selling out during the quarter.
Think Investments sold 186,373 Taro Pharmaceutical Industries Ltd. shares in Q1 2016, an estimated $28.8M.
Think Investments first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and held it in 5 quarters.
Think Investments's Taro Pharmaceutical Industries Ltd. position peaked at $31.2M in Q3 2015.
167 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2016.

Based on Think Investments's 13F filing for Q1 2016, filed 16 May 2016.